Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00213928 · ClinicalTrials.gov registry record · Phase 2
Horse Chestnut Seed Extract for Lymphedema
A Phase 2 study of Lymphedema of Arm, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT00213928: Completed Phase 2 study of Lymphedema of Arm, sponsored by University of Wisconsin, Madison.
NCT00213928 is a Phase 2 study of Lymphedema of Arm that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 56 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00213928, a Phase 2 study of Lymphedema of Arm, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
To help Treat Lymphedema of the Arm in Breast Cancer Survivors with Horse chestnut Seed Extract
Conditions Studied
Interventions
- DRUG Horse Chestnut Seed Extract
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2002-05 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
What the finished NCT00213928 record still lists
NCT00213928 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Lymphedema of Arm appearing as the primary indexed condition, and to 1 intervention - of which Horse Chestnut Seed Extract is the first listed.
NCT00213928 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00213928 about?
NCT00213928 is a clinical study titled "Horse Chestnut Seed Extract for Lymphedema". To help Treat Lymphedema of the Arm in Breast Cancer Survivors with Horse chestnut Seed Extract
What is the current status of trial NCT00213928?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 56 participants. The study started on 2002-05. Estimated completion is 2008-09.
What conditions does trial NCT00213928 study?
This clinical trial studies the following conditions: Lymphedema of Arm.
What interventions are being tested in trial NCT00213928?
The interventions under investigation include: Horse Chestnut Seed Extract (DRUG).
Who is sponsoring clinical trial NCT00213928?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00213928 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00213928's enrollment target sits among peer trials
56 1146th of 2000 higher than 848 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia